Baird Financial Group, Inc. Accelerate Diagnostics, Inc Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.54 - $1.41 $924,219 - $2.41 Million	-1,711,518 Reduced 98.28%	30,029 $30,000
Q1 2022 May 13, 2022	BUY	$1.4 - $5.15 $326,869 - $1.2 Million	233,478 Added 15.48%	1,741,547 $2.51 Million
Q4 2021 Feb 09, 2022	BUY	$4.27 - $6.97 $1.71 Million - $2.79 Million	400,169 Added 36.12%	1,508,069 $7.87 Million
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $382,049 - $593,579	71,949 Added 6.95%	1,107,900 $6.46 Million
Q2 2021 Aug 11, 2021	BUY	$6.81 - $9.23 $348,767 - $472,705	51,214 Added 5.2%	1,035,951 $8.35 Million
Q1 2021 May 13, 2021	BUY	$7.99 - $15.0 $58,742 - $110,280	7,352 Added 0.75%	984,737 $8.19 Million
Q4 2020 Feb 11, 2021	BUY	$7.04 - $11.7 $183,040 - $304,200	26,000 Added 2.73%	977,385 $7.41 Million
Q3 2020 Nov 12, 2020	SELL	$9.98 - $18.04 $133,322 - $240,996	-13,359 Reduced 1.38%	951,385 $10.1 Million
Q2 2020 Oct 22, 2020	BUY	$7.49 - $15.16 $4.06 Million - $8.21 Million	541,744 Added 128.07%	964,744 $14.6 Million
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $883,340 - $1.79 Million	-117,936 Reduced 21.8%	423,000 $7.15 Million
Q1 2020 May 14, 2020	BUY	$4.62 - $18.74 $434,894 - $1.76 Million	94,133 Added 21.07%	540,936 $4.51 Million
Q4 2019 Feb 14, 2020	BUY	$14.6 - $18.13 $392,871 - $487,860	26,909 Added 6.41%	446,803 $7.55 Million
Q3 2019 Nov 14, 2019	BUY	$16.62 - $23.92 $364,327 - $524,350	21,921 Added 5.51%	419,894 $7.8 Million
Q2 2019 Aug 14, 2019	BUY	$17.79 - $22.88 $101,829 - $130,965	5,724 Added 1.46%	397,973 $9.11 Million
Q1 2019 May 14, 2019	SELL	$11.76 - $22.15 $580,744 - $1.09 Million	-49,383 Reduced 11.18%	392,249 $8.25 Million
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $2.92 Million - $6.14 Million	279,895 Added 173.06%	441,632 $5.08 Million
Q3 2018 Nov 13, 2018	BUY	$20.4 - $24.6 $150,511 - $181,498	7,378 Added 4.78%	161,737 $3.55 Million
Q2 2018 Aug 13, 2018	BUY	$19.02 - $24.95 $104,172 - $136,651	5,477 Added 3.68%	154,359 $3.44 Million
Q1 2018 May 14, 2018	BUY	$22.55 - $29.9 $1.13 Million - $1.5 Million	50,264 Added 50.97%	148,882 $3.4 Million
Q4 2017 Feb 09, 2018	BUY	$18.0 - $30.0 $1.78 Million - $2.96 Million	98,618	98,618 $2.58 Million

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account